Salk research focuses on the development of compounds that may protect against the diseases of aging, such as Alzheimer’s
One of the hallmark traits of Alzheimer’s disease, a debilitating disorder marked by memory deficits and general cognitive decline, is the accumulation in the brain of a protein called b-amyloid. These proteins form “plaques” and bind to unique proteins on the surface of brain cells called receptors, causing widespread cell death.
Diagnosing Alzheimer's disease can be difficult, as several other conditions can cause similar symptoms. Now a new brain imaging method can show the spread of specific tau protein depositions, which are unique to cases with Alzheimer's.
Analysis of large data sets from post-mortem brain samples of people with and without Alzheimer's disease has revealed new evidence that viral species, particularly herpesviruses, may have a role in Alzheimer's disease biology.
Salk scientists improve the growth of three-dimensional brain models to better understand autism, dementia, schizophrenia
A blood test for Alzheimer’s disease, developed and validated by scientists from Japan and Australia, could speed up the pace of Alzheimer’s disease drug trials.